THC BIOMED INTL LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0158 USD | 0.00% |
|
+209.80% | +5.33% |
| Sales 2021 | 2.63M 1.92M 160M | Sales 2022 | 2.45M 1.79M 150M | Capitalization | 7.38M 5.39M 450M |
|---|---|---|---|---|---|
| Net income 2021 | -6M -4.38M -366M | Net income 2022 | -3M -2.19M -183M | EV / Sales 2021 | 8.24 x |
| Net Debt 2021 | 4.46M 3.26M 272M | Net Debt 2022 | 4M 2.93M 244M | EV / Sales 2022 | 4.65 x |
| P/E ratio 2021 |
-2.7
x | P/E ratio 2022 |
-2.41
x | Employees | 35 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 68.87% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | +209.80% | ||
| Current month | +409.68% | ||
| 1 month | +409.68% | ||
| 3 months | +42.34% | ||
| 6 months | +1.94% | ||
| Current year | +5.33% |
1 week
0.00
0.02
1 month
0.000.02
Current year
0.000.02
1 year
0.000.03
3 years
0.000.09
5 years
0.000.27
10 years
0.002.65
| Managers | Title | Age | Since |
|---|---|---|---|
John Miller
CEO | Chief Executive Officer | 57 | 14/15/14 |
Hee Jung Chun
DFI | Director of Finance/CFO | 48 | 14/15/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hee Jung Chun
DFI | Director of Finance/CFO | 48 | 14/15/14 |
John Miller
CEO | Chief Executive Officer | 57 | 14/15/14 |
Ashish Dave
BRD | Director/Board Member | - | 13/17/13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/24/17 | 0.0158 | 0.00% | 85 342 |
| 15/24/15 | 0.0158 | +31.67% | 47,500 |
| 12/24/12 | 0.012 | 0.00% | 65,050 |
| 11/24/11 | 0.012 | +12.15% | 55,700 |
| 10/24/10 | 0.0107 | +111.88% | 30,348 |
Delayed Quote OTC Markets, July 17, 2024 at 01:14 am IST
More quotes
THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.94% | 4.99B | |
| -32.21% | 3.61B | |
| -1.43% | 3.1B | |
| -25.09% | 2.64B | |
| -11.46% | 2.32B | |
| +36.65% | 1.85B | |
| +37.15% | 1.43B | |
| -16.01% | 1.39B | |
| +40.95% | 1.37B |
- Stock Market
- Equities
- THC Stock
- THCBF Stock
